According to Nabriva Therapeutics 's latest financial reports the company's total assets are $24.33 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $31.76 M | -60.74% |
2021-12-31 | $80.9 M | 38.46% |
2020-12-31 | $58.43 M | -37.91% |
2019-12-31 | $94.11 M | -14.77% |
2018-12-31 | $0.11 B | 15.3% |
2017-12-31 | $95.76 M | 2.71% |
2016-12-31 | $93.24 M | -21.12% |
2015-12-31 | $0.11 B | 2352.95% |
2014-12-31 | $4.81 M | -34.45% |
2013-12-31 | $7.35 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.25 B | 935.45% | ๐บ๐ธ USA |